China China’s new Amended Drug Administration Law is being enacted to strengthen and streamline its regulation of the pharmaceutical industry as well as address prominent problems such as counterfeit drugs, substandard drugs and high drug prices. Fangda Partners’ Josh Shin explains how the new law strengthens penalties for counterfeit and substandard…
Bulgaria Illiana Paunova is the first Executive Director and one of the founders of the Bulgarian Medicines Verification Organization (BgMVO), an organization which has been set up to fight against the counterfeit medicines in the country. She explains the BgMVO’s role as well as objectives within the pharmaceutical industry as the…
Switzerland “Robust solutions, the capability to implement them and the ability to do so globally” – The executive president of product and brand protection solutions at SICPA explains why the company is the right partner for companies in the pharmaceutical, healthcare and life science industry to fight counterfeiters. You joined SICPA…
See our Cookie Privacy Policy Here